These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4353104)

  • 1. [Azathioprine and hepatic functional structures (clinical and experimental studies)].
    Nicolaescu T; Bittman E; Stoiculescu P; Bordeianu A; Ciontescu L
    Rev Roum Physiol; 1973; 10(4):281-7. PubMed ID: 4353104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological implications in hepatic physiopathology].
    Nicolaescu T
    Rev Roum Physiol; 1971; 8(4):313-22. PubMed ID: 5128516
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoaggression and immunodepression in chronic hepatitis physiopathology.
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Boroş I; Moucha R; Jinga V; Gheorghe N; Metz L; Ciontescu L; Pintilescu V
    Rev Roum Physiol; 1974; 11(3):239-52. PubMed ID: 4842047
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic hepatitis.
    Mistilis SP; Lam KC
    Prog Liver Dis; 1972; 4():419-32. PubMed ID: 4569006
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. 3. Evolution of the immunologic picture. IV. Improvement of the functional parameters].
    Nicolescu T; Bittman E; Stoiculescu P; Bordeianu A; Boroş I; Jinga V; Moucha R; Ciontescu L
    Med Interna (Bucur); 1974 Apr; 26(4):465-78. PubMed ID: 4839353
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive drugs in the treatment of liver diseases (author's transl)].
    Magnenat P
    Ther Umsch; 1979 May; 36(5):432-8. PubMed ID: 451956
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process].
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L
    Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of apholate (ENT 26316; NSC 26812) on nucleic acids, total protein content & activity levels of aminotransferases (GOT, GPT), alkaline phosphatase & 5'-nucleotidase in liver of male albino rats.
    Haqqi TM; Adhami UM
    Indian J Exp Biol; 1979 May; 17(5):488-92. PubMed ID: 230151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical course observations of children with chronic aggressive hepatitis and liver cirrhosis during immunosuppressive therapy].
    Jeschke R; Gekle D; Franzen C
    Monatsschr Kinderheilkd (1902); 1980 May; 128(5):261-3. PubMed ID: 7421831
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppressive therapy in chronic liver disease.
    Sherlock S
    Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy with immunosuppressive agents in hepatology].
    Kleine FD; Keitel W; Franke A
    Z Gesamte Inn Med; 1969 Jun; 24(12):372-7. PubMed ID: 5404297
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reflections on prednisone therapy of patients with liver diseases].
    Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
    [No Abstract]   [Full Text] [Related]  

  • 13. Influences of azathiprine and prednisone on rat liver regeneration.
    Kort WJ; van der Post J
    Eur Surg Res; 1973; 5(5):373-83. PubMed ID: 4787211
    [No Abstract]   [Full Text] [Related]  

  • 14. [Penicillamine therapy of chronic liver diseases].
    Wildhirt E
    MMW Munch Med Wochenschr; 1974 Feb; 116(5):217-20. PubMed ID: 4205098
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary results of immunosuppressive treatment in chronic liver diseases].
    Perings E; Hunstein W; Creutzfeldt W
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):209-12. PubMed ID: 5732398
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Prednisone and azathioprine treatment of liver disease.
    Toth IG
    Gastroenterology; 1975 May; 68(5 Pt 1):1328. PubMed ID: 1126605
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glucocorticoids in chronic liver diseases].
    Maier KP; Talke H; Gerok W
    Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of an hepatic analeptic by enzyme determinations and hepatic clearance tests].
    Boisson J
    Ann Gastroenterol Hepatol (Paris); 1972; 8(2):191-6. PubMed ID: 5056542
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K; Hüdepohl M; Schopen RD
    Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.